A Fruit and Vegetable Prescription Program
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMilton S. Hershey Medical Center
About this trial
Dietary intake of fruits and vegetables (F\&V) is a cornerstone for the treatment of type 2 diabetes, however less than 16% of Hispanic adults consume the recommended number of servings each day. F\&V prescription (F\&V Rx) programs are embedded into clinical settings and provide patients with vouchers to purchase F\&V at local retailers. The proposed study aims to test the effects of a F\&V Rx on diabetes self-management education and support (DSME/S) uptake and retention, dietary intake of F\&V and diet quality, glucose control (hemoglobin A1c), and program implementation outcomes.
Eligibility criteria
Qualifiers
Patient at Penn State Health St. Joe's Medical Center
Diagnosis of Type 2 Diabetes Mellitus greater than or equal to six months
A1c level is greater than or equal to 7% (53 mmol/mol)
Low income defined as enrolled in Supplemental Nutrition Assistance Program (SNAP), is uninsured or have Medicaid, or identifying as food insecure based on USDA criteria.
Disqualifiers
Diagnosis of Type 2 Diabetes Mellitus less than six months
Patients who have previously participated in the Veggie Rx program in the past year
Patients who have attended any diabetes self-management education and support (DSME/S) sessions in the past year
Women who are pregnant or who plan to become pregnant during the study period
Trial design
Treatments tested in this trial
- Usual Care
- F&V Rx alone
- F&V Rx plus DSME/S
Treatment groups
120 Participants
are divided into 3 treatment groupsSponsors and collaborators
Milton S. Hershey Medical Center
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov